Buy 2, Get 1 Free — every compound, automaticFree shipping on orders over $100Free BPC-157 with orders over $150Buy 2, Get 1 Free — every compound, automaticFree shipping on orders over $100Free BPC-157 with orders over $150Buy 2, Get 1 Free — every compound, automaticFree shipping on orders over $100Free BPC-157 with orders over $150
The journal

Research notes, lab guides, quality essays.

What we're reading, learning, and shipping. Plain-language notes from the lab.

Research spotlight

BPC-157: A Plain-Language Overview of the Research

What the published preclinical literature has actually explored about BPC-157 — its structure, the research areas it appears in, and the limits of the current evidence. For laboratory and research use only.

July 2, 2026
Quality & testing

How to Read a Compound Certificate of Analysis (CoA)

A plain-language guide to interpreting a compound Certificate of Analysis, from HPLC purity percentages to mass-spectrometry identity confirmation, so laboratory researchers can evaluate what a lot's documentation actually shows.

June 24, 2026
Research spotlight

Tesamorelin: A Research Literature Overview

An educational overview of the published research literature on tesamorelin, a stabilized GHRH analog examined in laboratory and clinical research models in relation to the growth hormone axis and metabolic endpoints.

June 15, 2026
Research spotlight

MOTS-c: An Overview of the Mitochondrial-Compound Research

An educational overview of MOTS-c, a mitochondrial-derived compound studied in preclinical metabolic, exercise, and cellular-stress research models.

June 5, 2026
Research spotlight

NAD+ in Research: A Plain-Language Overview

A plain-language look at what published preclinical research has explored about NAD+ (nicotinamide adenine dinucleotide) in cellular metabolism and aging biology, framed for laboratory and research context only.

May 27, 2026
Research spotlight

Semax: What the Nootropic Compound Research Explores

A research-framed overview of Semax, an ACTH(4-10)-derived compound, and what preclinical laboratory studies have explored regarding neurotrophic signaling, monoamine systems, and models of cognition and ischemia.

May 15, 2026
Research spotlight

Selank: A Plain-Language Research Overview

A plain-language look at Selank, a synthetic tuftsin-analog compound, and what published preclinical research has explored regarding its neurochemistry, framed strictly for laboratory research use.

May 6, 2026
Research spotlight

Retatrutide: The Triple-Agonist Research Story

An educational overview of Retatrutide, an investigational GIP/GLP-1/glucagon triple receptor agonist, and what published preclinical and early-phase research has explored about its mechanism in laboratory and animal models.

April 24, 2026
Research spotlight

Tirzepatide: A GIP/GLP-1 Research Overview

An evergreen research overview of tirzepatide, a dual GIP/GLP-1 receptor agonist compound, summarizing what preclinical laboratory and animal-model studies have explored about its receptor pharmacology and metabolic signaling.

April 13, 2026
Research spotlight

Semaglutide and the GLP-1 Research Landscape

An educational overview of semaglutide, a long-acting GLP-1 receptor agonist, and the preclinical research literature exploring GLP-1 signaling across metabolic, cardiovascular, and neurobiological research models.

April 1, 2026
Research spotlight

CJC-1295 (No DAC): A Research Overview

A laboratory-focused overview of CJC-1295 without DAC (Modified GRF 1-29), a synthetic GHRH analog that has been studied as a tool compound in preclinical models of pituitary growth hormone signaling.

March 20, 2026
Research spotlight

Ipamorelin: An Overview of the Research Literature

A research-focused overview of Ipamorelin, a selective growth-hormone secretagogue compound, summarizing what preclinical laboratory and animal studies have explored about its receptor pharmacology, selectivity, and physiological correlates in research models.

March 9, 2026
Research spotlight

GHK-Cu: What the Copper-Compound Research Explores

An evergreen research overview of GHK-Cu (copper three-amino-acid compound-1), summarizing what preclinical laboratory studies have explored around collagen remodeling, gene expression, and copper biology.

February 25, 2026
Research spotlight

TB-500: A Plain-Language Overview of the Research

A research-focused, plain-language summary of what preclinical studies have explored regarding TB-500, a compound fragment related to the actin-binding protein Thymosin Beta-4.

February 13, 2026

More posts soon. Want a specific topic covered? Tell us.

Age & research-use verification

Research use only.

Meridian Compounds supplies compounds and reference compounds strictly for laboratory and scientific research. All products are sold for in-vitro research and development use only.

Our products are not drugs, foods, cosmetics, or dietary supplements. They are not intended to diagnose, treat, cure, or prevent any disease, and have not been evaluated by the Food and Drug Administration. Nothing on this site constitutes medical advice or a health claim.

Products are not for human or animal consumption or any in-vivo, diagnostic, or therapeutic use. By entering, you accept full responsibility for the lawful and appropriate handling of any product purchased.